For the Inventor, By the Inventor

Enter assignee name

Berlin, Germany

Bayer Pharma Aktiengesellschaft

USPTO Granted Patents = 378

CIPO Patents = 25

EPO Patents = 265

Trademarks = 19

Forward Citations = 1,194

Loading Chart...

Loading Chart...

841 inventors (with patents filed for the assignee):

Philip Lienau (51 out of 78 patents)

Gerhard Siemeister (37 out of 77 patents)

Frank Wunder (36 out of 97 patents)

4. Johannes-Peter Stasch (31 out of 150 patents)

5. Ulf Bömer (30 out of 65 patents)

6. Hanna Tinel (29 out of 32 patents)

7. Adrian Tersteegen (29 out of 52 patents)

8. Karl-Heinz Schlemmer (26 out of 120 patents)

9. Knut Eis (26 out of 41 patents)

10. Alexandros Vakalopoulos (26 out of 51 patents)

11. Martina Schäfer (24 out of 30 patents)

12. Johannes Platzek (23 out of 127 patents)

13. Ulrich Klar (23 out of 77 patents)

14. Antje Margret Wengner (23 out of 29 patents)

15. Anja Buchmüller (23 out of 29 patents)

Core Competencies:

Gadolinium Chelate Compounds

Soluble Guanylate Cyclase Activators

Indazole Derivatives

Bradykinin B1 Receptor Antagonists

Cancer Treatment Compositions

Antibody Drug Conjugates

PDE3A Inhibitors

ATR Kinase Inhibitors

Prodrugs of Cytotoxic Agents

Autoimmune Disease Treatments

Magnetic Resonance Imaging

Dihydrooxadiazinones

378 patents: Sort by Forward Citations

1. 12486248 - 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH (2025-12-02),

2. 12478696 - Gadolinium chelate compounds for use in magnetic resonance imaging (2025-11-25),

3. 12459916 - Substituted indazoles useful for treatment and prevention of allergic and/or inflammatory diseases in animals (2025-11-04),

4. 12427131 - Stimulators and/or activators of soluble guanylate cyclase (sGC) in combination with an inhibitor of neutral endopeptidase (NEP inhibitor) and/or an angiotensin AII antagonist and the use thereof (2025-09-30),

5. 12358877 - Synthesis of 4-amino-5-methyl-1H-pyridin-2(1H)-on (intermediate compound for the synthesis of the MR antagonist finerenone) from 2-chloro-5-methyl-4-nitro-pyridine-1-oxide using the intermediate compound 2-chloro-5-methyl-4-pyridinamine (2025-07-15),

6. 12303573 - Formulation of contrast media and process of preparation thereof (2025-05-20),

7. 12258343 - Method for preparing 2-[(3R)-3-methylmorpholin-4-yl]-4-[1-methyl-1H-pyrazol-5-yl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridine (2025-03-25),

8. 12258323 - Dihydrooxadiazinones (2025-03-25),

9. 12239630 - Carboxylic acid aromatic amides as antagonists of bradykinin B1 receptor (2025-03-04),

10. 12202805 - Process for preparing (5S)-{[2-(4-carboxyphenyl)ethyl] |2-(2-{|3-chloro-4'-(trifluoromethyl)biphenyl-4-yl]methoxy}phenyl)ethyl]aminol-5,6,7,8-tetrahydroquinoline-2-carboxylic acid and its crystalline forms for use as pharmaceutically active compound (2025-01-21),

11. 12180227 - Diazabicyclic substituted imidazopyrimidines and their use for the treatment of breathing disorders (2024-12-31),

12. 12152041 - Macrocyclic fluorine substituted indole derivatives (2024-11-26),

13. 12152006 - Process for preparing 4-amino-5-methylpyridone (2024-11-26),

14. 12144865 - Antibody drug conjugates with enzymatically cleavable groups (2024-11-19),

15. 12138256 - Treatment of cardiopulmonary disorders (2024-11-12),

BAYER PHARMA AKTIENGESELLSCHAFT is a global pharmaceutical company. They develop, manufacture, and market innovative medicines and medical products to improve people's lives. Committed to scientific excellence, they focus on research and development in therapeutic areas like cardiology, oncology, women's health, and ophthalmology. With a mission to shape the future of healthcare, they strive to address unmet medical needs and provide effective healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

378 Patents

#2 in D-1000 Berlin

#163 in Germany

#2,366 in the World

Berlin, Germany

Bayer Pharma Aktiengesellschaft

Forward Citations = 1,194

841 inventors:

Philip Lienau (51 out of 78 patents)

Gerhard Siemeister (37 out of 77 patents)

Frank Wunder (36 out of 97 patents)

4. Johannes-Peter Stasch (31 out of 150 patents)

5. Ulf Bömer (30 out of 65 patents)

Please report any incorrect information to support@idiyas.com

Loading…